Skip to main content
Log in

Considerazioni sulla proprieta' insulino-legante del siero del soggetto normale e del diabetico mai trattato con insulina

  • Lavori Originali
  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Riassunto

Gli AA. rilevano che i sieri dell'individuo normale e del diabetico mai trattato con insulina sono provvisti di proprietà insulino-legante di entità analoga. In alcuni sieri, sia del soggetto normale che del diabetico, è presente un'attività insulino-legante superiore ai valori massimi normali, che diminuisce dopo aggiunta di µU 500 di insulina bovina.

Gli AA. fanno alcune considerazioni interpretative su tale fenomeno.

Resume

Les AA. ont observé que le sérum d'un sujet normal et celui d'un diabétique, jamais traité avec insuline, ont la possibilité de lier l'insuline dans la même mesure. Dans certains sérums, soit du sujet normal soit du diabétique, est présente une activité de liaison de l'insuline supérieure aux taux normaux plus élevés; cette activité diminue après administration de µU 500 d'insuline bovine.

Les AA. présentent leurs considérations à propos de ce phénomène.

Resumen

Los AA. observan que los sueros del individuo normal y del diabético nunca tratado con insulina poseen propiedades insulino-ligantes de entidad análoga. En algunos sueros — ya del sujeto normal, ya del diabético — está presente una actividad insulino-ligante superior a los valores máximos normales, que disminuye luego de haber agregado µU 500 de insulina bovina.

Los AA. hacen algunas consideraciones interpretativas de tal fenómeno.

Zusammenfassung

Die AA. stellen fest, daß das Blutserum des normalen Menschen und des Diabetikers, der nie mit Insulin behandelt wurde, ähnliche Insulin-bindende Eigenschaften aufweisen. In manchen Blutseren, sowohl beim normalen, als auch beim diabetischen Menschen, ist eine Insulin-bindende Aktivität vorhanden, die die maximalen normalen Meßwerte überschreitet und nach Zusatz von µU 500 Rinderinsulin sinkt.

Die AA. geben zu diesem Phänomen einige Erläuterungen.

Summary

The AA. report that the sera of normal subjects and diabetics never treated with insulin have similar insulin-binding properties. In a few sera, either from normal or diabetic subjects, an insulinbinding capacity may be found which is higher than maximum normal values and decreases after addition of µU 500 of beef insulin.

The AA. present some explanatory remarks on this phenomenon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliografia

  1. Arquilla E. R., Stavitsky A. B.: The Production and Identification of Antibodies to Insulin and their Use in Assaying Insulin - J. clin. Invest.35 458, 1956.

    Google Scholar 

  2. Berson S. A., Yalow R. S.: Radiochemical and Radiobiological Alterations of I131 Labelled Proteins in Solution - Ann. N.Y. Acad. Sci.70 56, 1957.

    PubMed  Google Scholar 

  3. Berson S. A., Yalow R. S.: Recent Studies on Insulin-Binding Antibodies- Ann. N.Y. Acad. Sci.82 338, 1959.

    PubMed  Google Scholar 

  4. Berson S. A., Yalow R. S.: The Present Status of Insulin Antagonists in Plasma - Diabetes13 247, 1964.

    PubMed  Google Scholar 

  5. Berson S. A., Yalow R. S., Bauman A., Rothschild M. A., Newerly K.: Insulin I131 Metabolism in Human Subjects: Demonstration of Insulin Binding Globulin in the Circulation of Insulin Treated Subjects - J. clin. Invest.35 170, 1956.

    PubMed  Google Scholar 

  6. Bolinger R. E., Van Der Geld H., Willenbrands A. F., Groen J.: Onderzoek naar het insulinegehalte van bloedserum met behulp van Koloneelectrophorese - Ned. T. Geneesk.102 700, 1958.

    PubMed  Google Scholar 

  7. Chetty M. P., Watson H. C.: Antibody-Like Activity in Diabetic and Normal Serum, Measured by Complement Consumption - Lancet1 67, 1965.

    Google Scholar 

  8. Federlin K., Heinemann G., Gigli I., Ditschuneit H.: Antigenbindung durch zirkulierende Leukozyten bei der verzögerten lokalen Insulinallergie - Dtsch. med. Wschr.91 914, 1966.

    Google Scholar 

  9. Frei P. C., Cruchaud S., Vannotti A.: Allergie à l'insuline de type cellulaire - Rev. franç. Étud. clin. biol.10 1083, 1965.

    Google Scholar 

  10. Kalant N., Gomberg C., Schucher R.: The Effect of Insulin-Binding Antibodies on Insulin Sensitivity - Lancet2 614, 1958.

    PubMed  Google Scholar 

  11. Kerp L., Steinhilber S., Kieling F., Creutzfeldt W.: Klinische und experimentelle Untersuchungen zur Insulinallergie und Insulinresistenz - Dtsch. med. Wschr.90 806, 1965.

    PubMed  Google Scholar 

  12. Lerman J.: Insulin Resistance, Role of Immunity in its Production - Amer. J. med. Sci.207 354, 1944.

    Google Scholar 

  13. Loveless M. H., Cann J. R.: Distribution of Allergic and Blocking Activity in Human Serum Proteins Fractionated by Electrophoresis Convection - Science117 105, 1953.

    PubMed  Google Scholar 

  14. Lowell F. C.: Evidence for the Existence of two Antibodies for Crystalline Insulin - Proc. Soc. exp. Biol. (N.Y.)50 167, 1942.

    Google Scholar 

  15. Lowell F. C.: Immunologic Studies in Insulin Resistance. III. Measurement of an Insulin Antagonist in the Serum of an Insulin-Resistant Patient by the Blood Sugar Curve Method in Mice - J. clin. Invest.26 57, 1947.

    Google Scholar 

  16. Mancini A. M., Zampa G. A., Vecchi A., Costanzi G.: Histoimmunological Techniques for Detecting Anti-Insulin Antibodies in Human Sera - Lancet1 1189, 1965.

    Google Scholar 

  17. Motta L., Lunetta M., Calcagno G., Lombardo T.: Determinazione radioimmunologica degli anticorpi antiinsulina col metodo della precipitazione alcoolica - Minerva med. (in corso di stampa).

  18. Pav J., Jezkovà Z., Skrha F.: Insulin Antibodies - Lancet2 221, 1963.

    PubMed  Google Scholar 

  19. Pentschev J., Andreev D., Ditzov S.: Insulinpraezipitierende Antikoerper bei insulinbehandelten und unbehandelten Diabetikern und in mit Insulin immunisierten Meerschweinchen -Acta Diab. Latina2 454, 1965.

    Google Scholar 

  20. Prout T. E., Odak V. V., Dendrinos G. J.: The Role of Alpha-Globulins as an Insulin-Carrying Protein in Human Sera - J. clin. Invest.40 1073, 1961.

    Google Scholar 

  21. Rosselin G., Tchobroutsky G., Assan R., Lellouch J., Dolais J., Derot M.: Etude quantitative d'anticorps humains anti-insulines animales par la méthode radio-immunologique de Berson et Yalow. Comportement des antiserum vis à vis d'insulines bovine, porcine et humaine - Diabetologia1 33, 1965.

    Google Scholar 

  22. Sirek O. V., Sirek A.: Studies of Insulin I131 Binding to Plasma Proteins of a Houssay Dog -Acta Diab. Latina2 299, 1965.

    Google Scholar 

  23. Skom J. H., Talmage D. W.: Nonprecipitating Insulin Antibodies -J. clin. Invest.37 783, 1958.

    PubMed  Google Scholar 

  24. Steigerwald H., Spielmann W., Friess H., Grebe S. F.: Neuere Untersuchungen ueber die Antigenwirkung der Insuline - Klin. Wschr.38 973, 1960.

    Google Scholar 

  25. Vaerman J., Epstein W., Fudenberg H.: Direct Demonstration of Reagin Activity in Purified Gamma1A-Globulin - Nature203 1046, 1964.

    PubMed  Google Scholar 

  26. Welborn T. A., Richards R., Fraser T. R.: Simple Test for Insulin Antibodies in Sera, Using I131-Insulin and Ethanol Precipitation - Brit. Med. J.1 719, 1967.

    PubMed  Google Scholar 

  27. Yagi Y., Maier P., Pressman D., Arbesman C. E., Reisman R. E.: The Presence of the Ragweed-Binding Antibodies in the β2A-, β2M- and γ-Globulins of the Sensitive Individuals -J. Immunol.91 83, 1963.

    PubMed  Google Scholar 

  28. Yagi Y., Maier P., Pressman D., Arbesman C. E., Reisman R. E., Lenzer A. R.: Multiplicity of Insulin Binding Antibodies in Human Sera - Presence of Antibody Activity in γ-, β2A- and β2M-Globulins - J. Immunol.90 760, 1963.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lunetta, M., Calcagno, G., Motta, L. et al. Considerazioni sulla proprieta' insulino-legante del siero del soggetto normale e del diabetico mai trattato con insulina. Acta diabet. lat 5, 201–214 (1968). https://doi.org/10.1007/BF01543868

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01543868

Key-words

Navigation